Seer
IPORedwood City, United States · Founded 2017
- Headquarters
- Redwood City, California
- Employees
- 51–200
- Founded
- 2017
- Business Model
- B2B
- Last Round
- Series AJan 2017
- Rounds
- 1
About
Seer develops the Proteograph platform enabling deep, unbiased proteomics discovery at scale for life sciences and biomedical research.
Summary
Seer is a Biotech company based in Redwood City, United States, founded in 2017. Its most recent funding was a Series A round in Jan 2017. Investors include Maverick Ventures and Invus.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2020
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...